Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Correction: Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study.

Orozco-Beltran D, Gil-Guillen VF, Redon J, Martin-Moreno JM, Pallares-Carratala V, Navarro-Perez J, Valls-Roca F, Sanchis-Domenech C, Fernandez-Gimenez A, Perez-Navarro A, Bertomeu-Martinez V, Bertomeu-Gonzalez V, Cordero A, de la Torre MP, Trillo JL, Carratala-Munuera C, Pita-Fernandez S, Uso R, Durazo-Arvizu R, Cooper R, Sanz G, Castellano JM, Ascaso JF, Carmena R, Tellez-Plaza M; ESCARVAL Study Group.

PLoS One. 2018 Sep 27;13(9):e0205047. doi: 10.1371/journal.pone.0205047. eCollection 2018.

2.

Mortality and cardiovascular disease burden of uncontrolled diabetes in a registry-based cohort: the ESCARVAL-risk study.

Navarro-Pérez J, Orozco-Beltran D, Gil-Guillen V, Pallares V, Valls F, Fernandez A, Perez-Navarro AM, Sanchis C, Dominguez-Lucas A, Martin-Moreno JM, Redon J, Tellez-Plaza M; ESCARVAL STUDY GROUP.

BMC Cardiovasc Disord. 2018 Sep 4;18(1):180. doi: 10.1186/s12872-018-0914-1.

3.

Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2018.

Brotons Cuixart C, Alemán Sánchez JJ, Banegas Banegas JR, Fondón León C, Lobos-Bejarano JM, Martín Rioboó E, Navarro Pérez J, Orozco-Beltrán D, Villar Álvarez F; Grupo de Prevención Cardiovascular del PAPPS.

Aten Primaria. 2018 May;50 Suppl 1:4-28. doi: 10.1016/S0212-6567(18)30360-3. Spanish. No abstract available.

PMID:
29866357
Free Article
4.

Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study.

Orozco-Beltran D, Gil-Guillen VF, Redon J, Martin-Moreno JM, Pallares-Carratala V, Navarro-Perez J, Valls-Roca F, Sanchis-Domenech C, Fernandez-Gimenez A, Perez-Navarro A, Bertomeu-Martinez V, Bertomeu-Gonzalez V, Cordero A, Pascual de la Torre M, Trillo JL, Carratala-Munuera C, Pita-Fernandez S, Uso R, Durazo-Arvizu R, Cooper R, Sanz G, Castellano JM, Ascaso JF, Carmena R, Tellez-Plaza M; ESCARVAL Study Group.

PLoS One. 2017 Oct 18;12(10):e0186196. doi: 10.1371/journal.pone.0186196. eCollection 2017. Erratum in: PLoS One. 2018 Sep 27;13(9):e0205047.

5.

Clinical applicability and cost-effectiveness of DIABSCORE in screening for type 2 diabetes in primary care.

Rodríguez-Pérez MC, Orozco-Beltrán D, Gil-Guillén V, Domínguez-Coello S, Almeida-González D, Brito-Díaz B, Marcelino-Rodríguez I, Carratalá-Munuera MC, Gómez-Moreno N, Navarro-Perez J, Brotons-Munto F, Pertusa-Martinez S, Cabrera de León A.

Diabetes Res Clin Pract. 2017 Aug;130:15-23. doi: 10.1016/j.diabres.2017.05.009. Epub 2017 May 12.

PMID:
28551481
6.

Saxagliptin and Heart Failure in the SAVOR-TIMI 53 Trial: Reflections on the Bradford Hill Criteria.

Cebrián Cuenca AM, Orozco Beltrán D, Navarro Pérez J, Álvarez-Guisasola F, Núñez Villota J, Consuegra-Sánchez L.

Rev Esp Cardiol (Engl Ed). 2017 Dec;70(12):1143-1144. doi: 10.1016/j.rec.2017.02.023. Epub 2017 Mar 9. Review. English, Spanish. No abstract available.

PMID:
28284632
7.

Renal function and attributable risk of death and cardiovascular hospitalization in patients with cardiovascular risk factors from a registry-based cohort: the Estudio Cardiovascular Valencia-risk study.

Tellez-Plaza M, Orozco-Beltran D, Gil-Guillen V, Pita-Fernandez S, Navarro-Pérez J, Pallares V, Valls F, Fernandez A, Perez-Navarro AM, Sanchis C, Dominguez-Lucas A, Martin-Moreno JM, Redon J; ESCARVAL STUDY GROUP.

J Hypertens. 2016 Nov;34(11):2266-73. doi: 10.1097/HJH.0000000000001089.

PMID:
27584973
8.

Saxagliptin and risk of heart failure hospitalization: Concern or miscalculation?

Cebrián-Cuenca AM, Orozco-Beltrán D, Navarro-Pérez J, Franch-Nadal J, Núñez-Villota J, Consuegra-Sánchez L.

Int J Cardiol. 2016 Oct 1;220:573-4. doi: 10.1016/j.ijcard.2016.06.269. Epub 2016 Jun 29. No abstract available.

PMID:
27390991
9.

Recomendaciones preventivas cardiovasculares. PAPPS 2016.

Maiques Galán A, Brotons Cuixart C, Banegas Banegas JR, Martín Rioboó E, Lobos-Bejarano JM, Álvarez FV, Alemán Sánchez JJ, Navarro Pérez J, Orozco-Beltrán D, León CF, Gil Guillén V.

Aten Primaria. 2016 Jun;48 Suppl 1:4-26. doi: 10.1016/S0212-6567(16)30185-8. Spanish. No abstract available.

10.

Impact of hypertension on mortality and cardiovascular disease burden in patients with cardiovascular risk factors from a general practice setting: the ESCARVAL-risk study.

Redon J, Tellez-Plaza M, Orozco-Beltran D, Gil-Guillen V, Pita Fernandez S, Navarro-Pérez J, Pallares V, Valls F, Fernandez A, Perez-Navarro AM, Sanchis C, Dominguez-Lucas A, Sanz G, Martin-Moreno JM; ESCARVAL Study Group.

J Hypertens. 2016 Jun;34(6):1075-83. doi: 10.1097/HJH.0000000000000930.

PMID:
27074896
11.

Patients' and physicians' preferences for type 2 diabetes mellitus treatments in Spain and Portugal: a discrete choice experiment.

Morillas C, Feliciano R, Catalina PF, Ponte C, Botella M, Rodrigues J, Esmatjes E, Lafita J, Lizán L, Llorente I, Morales C, Navarro-Pérez J, Orozco-Beltran D, Paz S, Ramirez de Arellano A, Cardoso C, Tribaldos Causadias M.

Patient Prefer Adherence. 2015 Oct 14;9:1443-58. doi: 10.2147/PPA.S88022. eCollection 2015.

12.

[The PROPRESE trial: results of a new health care organizational model in primary care for patients with chronic coronary heart disease based on a multifactorial intervention].

Ruescas-Escolano E, Orozco-Beltran D, Gaubert-Tortosa M, Navarro-Palazón A, Cordero-Fort A, Navarro-Pérez J, Carratalá-Munuera C, Pertusa-Martínez S, Soler-Bahilo E, Brotons-Muntó F, Bort-Cubero J, Núñez-Martínez MA, Bertomeu-Martínez V, López-Pineda A, Gil-Guillén VF; en nombre de los investigadores del Proyecto PROPRESE.

Aten Primaria. 2014 Jun;46 Suppl 3:10-5. doi: 10.1016/S0212-6567(14)70060-5. Spanish.

13.

[Cardiovascular preventive recommendations].

Maiques Galán A, Brotons Cuixart C, Villar Álvarez F, Martín Rioboó E, Banegas Banegas JR, Navarro Pérez J, Alemán Sánchez JJ, Lobos-Bejarano JM, Ortega Sánchez-Pinilla R, Orozco-Beltrán D, Gil Guillén V; Grupo de Prevención Cardiovascular del PAPPS.

Aten Primaria. 2014 Jun;46 Suppl 4:3-15. doi: 10.1016/S0212-6567(14)70047-2. Spanish. No abstract available.

14.

Is the physician's behavior in dyslipidemia diagnosis in accordance with guidelines? Cross-sectional ESCARVAL study.

Palazón-Bru A, Gil-Guillén VF, Orozco-Beltrán D, Pallarés-Carratalá V, Valls-Roca F, Sanchís-Domenech C, Martín-Moreno JM, Redón J, Navarro-Pérez J, Fernández-Giménez A, Pérez-Navarro AM, Trillo JL, Usó R, Ruiz E.

PLoS One. 2014 Mar 13;9(3):e91567. doi: 10.1371/journal.pone.0091567. eCollection 2014.

15.

[Quality of care indicators for benign prostatic hyperplasia. A qualitative study].

Navarro-Pérez J, Peiró S, Brotons-Muntó F, López-Alcina E, Real-Romaguera A; en nombre del Grupo de trabajo del Programa de Formación e Investigación en Hiperplasia Benigna de Próstata de la Comunidad Valenciana.

Aten Primaria. 2014 May;46(5):231-7. doi: 10.1016/j.aprim.2013.09.005. Epub 2013 Dec 15. Spanish.

16.

[Dabigatran versus acenocumarol for the prevention of stroke in atrial fibrillation: budget impact analysis in one health department in Spain].

Bonet Pla A, Gosalbes Sóler V, Ridao-López M, Navarro Pérez J, Navarro Cubells B, Peiró S.

Rev Esp Salud Publica. 2013 Jul-Aug;87(4):331-42. doi: 10.4321/S1135-57272013000400004. Spanish.

17.

Effectiveness of a new health care organization model in primary care for chronic cardiovascular disease patients based on a multifactorial intervention: the PROPRESE randomized controlled trial.

Orozco-Beltran D, Ruescas-Escolano E, Navarro-Palazón AI, Cordero A, Gaubert-Tortosa M, Navarro-Perez J, Carratalá-Munuera C, Pertusa-Martínez S, Soler-Bahilo E, Brotons-Muntó F, Bort-Cubero J, Nuñez-Martinez MA, Bertomeu-Martinez V, Gil-Guillen VF; PROPRESE research team.

BMC Health Serv Res. 2013 Aug 2;13:293. doi: 10.1186/1472-6963-13-293.

18.

Barriers associated with poor control in Spanish diabetic patients. A consensus study.

Carratalá-Munuera MC, Gil-Guillen VF, Orozco-Beltran D, Navarro-Pérez J, Caballero-Martínez F, Alvarez-Guisasola F, García-Soidán J, Fluixá-Carrascosa C, Franch-Nadal J, Martín-Rioboó E, Carrillo-Fernández L, Artola-Menéndez S; “Integrated Management of Type 2 Diabetes Mellitus” Research Group.

Int J Clin Pract. 2013 Sep;67(9):888-94. doi: 10.1111/ijcp.12160. Epub 2013 Jun 12.

PMID:
23758484
19.

[Giving topical anaesthesia in the airway using the MADgic device with Glidescope video laryngoscope for the intubation of the awake patient].

Osseyran Samper F, Cuchillo Sastriques JV, Lluch Oltra A, Navarro Pérez JL, Barberá Alacreu ML.

Rev Esp Anestesiol Reanim. 2012 May;59(5):283-5. doi: 10.1016/j.redar.2012.02.005. Epub 2012 May 11. Spanish. No abstract available.

PMID:
22579016
20.

[Bibliometric analysis of International Scientific production on primary care].

Carratalá-Munuera MC, Orozco-Beltrán D, Gil-Guillen VF, Navarro-Perez J, Quirce F, Merino J, Basora J.

Aten Primaria. 2012 Nov;44(11):651-8. doi: 10.1016/j.aprim.2011.12.002. Epub 2012 Jan 31. Spanish.

Supplemental Content

Loading ...
Support Center